Search

everythinglearnresearchcommunity

for

Search:↓

Using growth factor injections and minoxidil together can significantly improve hair growth in people with hair loss.

AMH is a promising biomarker for diagnosing PCOS.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

α-MSH and cyclic AMP boost melanin production, while cyclic GMP and melatonin reduce it.

The dietary supplement AGA-P improves the effectiveness of hair loss treatments.

Adding a cosmetic gel with caffeine, taurine, and growth factors to standard hair loss treatments could improve results.

The 2003 Australian Medicines Handbook was a clear, concise drug reference guide, updated with new topics and evidence, and considered essential for medical practice.

The Mito-Activator Complex boosts hair growth by activating mitochondria.

A man with a new type of male pattern hair loss that affects the back of the head responded well to common hair loss treatments.

Researchers found a new ABCD1 gene mutation linked to a rare brain and nerve disorder with unusual brain changes.

PMC shows promise as a treatment for hair loss.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Human hair protein modifications could potentially indicate heart disease risk.

The hydrogel helps bone growth and healing in jaw and facial defects.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

The device improved hair growth and thickness in men without side effects.

Serum IMA levels don't help diagnose AGA but may indicate its severity.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Troponin I may help detect heart problems in people with Androgenetic Alopecia.

Stem cell treatment can effectively regrow hair.

Mesotherapy might help with hair growth in androgenic alopecia, but more research is needed.

Combining laser light therapy and growth factor treatment improves hair growth in people with hair loss.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

MRI reveals thinner scalps and smaller hair follicles in people with androgenetic alopecia.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

Men with severe hair loss may have a higher risk of heart disease.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

The treatment increased hair growth and thickness in patients with hair loss.